Aquestive Therapeutics (AQST) Institutional Ownership

$3.93
+0.03 (+0.77%)
(As of 04/25/2024 ET)

Institutional Ownership Changes (13F Filings) for Aquestive Therapeutics (NASDAQ:AQST)

Current
Institutional Ownership
Percentage
32.45%
Number of
Institutional Buyers
(last 12 months)
9
Total
Institutional Inflows
(last 12 months)
$9.20M
Number of
Institutional Sellers
(last 12 months)
4
Total
Institutional Outflows
(last 12 months)
$2.11M
Get AQST Insider Trade Alerts

Want to know when executives and insiders are buying or selling Aquestive Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

Skip Chart & View Institutional Buying and Selling Data

AQST Institutional Buying and Selling by Quarter

Aquestive Therapeutics Major Shareholders & Ownership History

Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
4/22/2024 PFG Investments LLC48,000$204K0.0%N/A0.065%
2/13/2024Armistice Capital LLC3,924,000$7.93M0.1%-18.3%5.877%
2/8/2024Essex Investment Management Co. LLC846,167$1.71M0.3%N/A1.267%
2/7/2024Jump Financial LLC29,812$60K0.0%N/A0.045%
1/25/2024Vahanian & Associates Financial Planning Inc.591,608$1.20M4.7%-18.1%0.886%
1/16/2024 Legato Capital Management LLC340,564$688K0.1%N/A0.510%
11/15/2023Armistice Capital LLC4,800,000$7.34M0.1%+314.5%7.189%
11/13/2023Connor Clark & Lunn Investment Management Ltd.247,828$379K0.0%+14.2%0.371%
11/13/2023Acadian Asset Management LLC550,484$841K0.0%+238.8%0.824%
8/8/2023Kestra Private Wealth Services LLC16,732$28K0.0%N/A0.030%
8/7/2023Acadian Asset Management LLC162,467$267K0.0%N/A0.291%
8/4/2023HBK Sorce Advisory LLC42,348$70K0.0%-50.0%0.076%
8/2/2023Bank of Montreal Can19,230$42K0.0%N/A0.034%
5/11/2023Financial Advocates Investment Management25,000$28K0.0%-21.9%0.045%
4/18/2023Vahanian & Associates Financial Planning Inc.718,908$820K2.3%+6.0%1.287%
2/1/2023Vahanian & Associates Financial Planning Inc.678,258$612K2.0%-2.4%1.252%
11/3/2022Vahanian & Associates Financial Planning Inc.695,258$813K2.8%+24.9%1.303%
8/11/2022Beacon Pointe Advisors LLC60,000$38K0.0%N/A0.112%
8/10/2022Mackenzie Financial Corp61,699$39K0.0%N/A0.116%
8/5/2022Cowen AND Company LLC124,590$80K0.0%N/A0.281%
7/27/2022Vahanian & Associates Financial Planning Inc.556,758$356K1.5%+7.0%1.257%
5/11/2022GSA Capital Partners LLP34,769$91K0.0%-64.4%0.083%
4/27/2022Vahanian & Associates Financial Planning Inc.520,158$1.36M3.1%-44.1%1.254%
4/19/2022Graypoint LLC413,817$1.08M0.1%N/A0.998%
2/14/2022PDT Partners LLC91,611$356K0.0%+20.4%0.228%
2/14/2022GSA Capital Partners LLP97,802$380K0.0%-67.1%0.244%
2/10/2022Connor Clark & Lunn Investment Management Ltd.28,382$110K0.0%N/A0.071%
2/4/2022IndexIQ Advisors LLC81,213$316K0.0%-6.1%0.202%
1/28/2022Vahanian & Associates Financial Planning Inc.929,975$3.62M2.9%N/A2.315%
12/1/2021Balyasny Asset Management LLC148,061$646K0.0%N/A0.369%
11/15/2021Balyasny Asset Management LLC148,061$646K0.0%N/A0.369%
11/15/2021GSA Capital Partners LLP297,229$1.30M0.1%+203.9%0.740%
11/12/2021Renaissance Technologies LLC189,669$827K0.0%-22.7%0.472%
11/12/2021Jump Financial LLC49,700$216K0.0%+62.3%0.124%
11/10/2021Goldman Sachs Group Inc.73,165$319K0.0%+7.5%0.182%
11/10/2021IndexIQ Advisors LLC86,461$377K0.0%+11.1%0.215%
11/9/2021Barclays PLC27,926$122K0.0%-11.0%0.070%
11/9/2021BlackRock Inc.330,946$1.44M0.0%-5.7%0.824%
9/17/2021Virtu Financial LLC18,521$74K0.0%N/A0.048%
8/17/2021Millennium Management LLC437,854$1.74M0.0%N/A1.126%
Jim Cramer’s “The Biggest Drug Ever” (Ad)

This firm's breakthrough has drawn investments from the biggest names in Big Pharma - With companies like Biogen, Sanofi, and Genentech pouring over $1 billion into it.

Unlock the details of this groundbreaking opportunity here...
8/17/2021Bridgeway Capital Management LLC127,000$504K0.0%-16.4%0.327%
8/17/2021Caas Capital Management LP217,091$862K0.0%N/A0.558%
8/16/2021Squarepoint Ops LLC19,824$79K0.0%N/A0.051%
8/16/2021LMR Partners LLP12,090$48K0.0%N/A0.031%
8/16/2021PDT Partners LLC81,765$325K0.0%N/A0.210%
8/16/2021Alberta Investment Management Corp150,000$596K0.0%N/A0.386%
8/16/2021Charles Schwab Investment Management Inc.74,757$297K0.0%-56.7%0.192%
8/16/2021State Street Corp69,877$277K0.0%-78.4%0.180%
8/16/2021Tibra Equities Europe Ltd78,100$310K0.1%N/A0.201%
8/16/2021Goldman Sachs Group Inc.68,030$270K0.0%+45.3%0.175%
8/13/2021Renaissance Technologies LLC245,448$974K0.0%N/A0.631%
8/13/2021Northern Trust Corp45,454$181K0.0%-78.6%0.117%
8/13/2021Jump Financial LLC30,630$122K0.0%N/A0.079%
8/13/2021Brandywine Global Investment Management LLC125,416$498K0.0%-7.9%0.323%
8/13/2021Latash Investments LLC243,134$965K0.6%N/A0.625%
8/13/2021Geode Capital Management LLC219,642$871K0.0%-38.1%0.565%
8/13/2021Vanguard Group Inc.1,046,078$4.15M0.0%+22.1%2.690%
8/12/2021JPMorgan Chase & Co.125,411$497K0.0%+238.3%0.323%
8/12/2021Bank of Montreal Can21,020$87K0.0%+365.6%0.054%
8/12/2021Ergoteles LLC90,900$361K0.0%N/A0.234%
8/11/2021Bank of New York Mellon Corp115,723$459K0.0%-29.5%0.298%
8/11/2021Susquehanna Fundamental Investments LLC15,644$62K0.0%N/A0.040%
8/10/2021Cresset Asset Management LLC25,000$99K0.0%N/A0.064%
8/6/2021HighTower Advisors LLC126,805$504K0.0%+84.8%0.347%
8/5/2021GSA Capital Partners LLP97,801$388K0.0%-52.9%0.267%
8/4/2021IndexIQ Advisors LLC77,801$309K0.0%-13.0%0.213%
8/3/2021Financial Advocates Investment Management17,000$67K0.0%+30.8%0.046%
6/17/2021Geneos Wealth Management Inc.23,300$94K0.0%N/A0.064%
5/18/2021Morgan Stanley358,042$1.86M0.0%+929.7%0.978%
5/18/2021Jane Street Group LLC13,360$69K0.0%-76.5%0.037%
5/17/2021Nuveen Asset Management LLC764,217$3.97M0.0%+43.9%2.088%
5/17/2021Goldman Sachs Group Inc.46,826$243K0.0%-8.5%0.128%
5/14/2021XTX Topco Ltd10,970$57K0.0%N/A0.030%
5/13/2021Trexquant Investment LP10,227$53K0.0%N/A0.028%
5/13/2021Barclays PLC16,612$86K0.0%+159.0%0.045%
5/13/2021Bank of New York Mellon Corp164,259$854K0.0%+82.5%0.449%
5/13/2021Massachusetts Financial Services Co. MA54,495$283K0.0%-10.6%0.149%
5/12/2021Northern Trust Corp212,402$1.10M0.0%-5.9%0.580%
5/12/2021Geode Capital Management LLC354,856$1.85M0.0%+13.3%0.970%
5/12/2021UBS Group AG14,174$74K0.0%-40.4%0.039%
5/11/2021Oak Grove Capital LLC15,500$81K0.0%-73.9%0.042%
5/10/2021HighTower Advisors LLC68,617$357K0.0%N/A0.188%
5/10/2021GSA Capital Partners LLP207,609$1.08M0.2%N/A0.567%
5/7/2021BlackRock Inc.1,356,400$7.05M0.0%+3.9%3.707%
5/7/2021IndexIQ Advisors LLC89,390$465K0.0%N/A0.259%
4/26/2021Wedbush Securities Inc.10,000$52K0.0%N/A0.029%
2/24/2021Virtu Financial LLC59,050$316K0.0%-49.6%0.176%
2/23/2021CWA Asset Management Group LLC11,284$60K0.0%N/A0.034%
2/19/2021JPMorgan Chase & Co.38,863$208K0.0%+187.5%0.116%
2/17/2021Oak Grove Capital LLC59,500$318K0.1%-33.1%0.177%
Jim Cramer’s “The Biggest Drug Ever” (Ad)

This firm's breakthrough has drawn investments from the biggest names in Big Pharma - With companies like Biogen, Sanofi, and Genentech pouring over $1 billion into it.

Unlock the details of this groundbreaking opportunity here...
2/17/2021Jane Street Group LLC56,752$304K0.0%-10.1%0.169%
2/16/2021Squarepoint Ops LLC42,797$229K0.0%N/A0.127%
2/16/2021Nuveen Asset Management LLC531,086$2.84M0.0%+329.1%1.580%
2/16/2021Engineers Gate Manager LP49,000$262K0.0%-28.3%0.146%
2/12/2021Financial Advocates Investment Management14,200$76K0.0%N/A0.042%
2/11/2021Northern Trust Corp225,604$1.21M0.0%-2.7%0.671%
2/11/2021Barclays PLC6,415$34K0.0%-29.4%0.019%
2/11/2021Citigroup Inc.10,138$54K0.0%+418.6%0.030%
2/10/2021Rhumbline Advisers19,740$106K0.0%+17.6%0.059%
2/10/2021Renaissance Technologies LLC271,800$1.45M0.0%N/A0.808%
(Data available from 1/1/2016 forward)

AQST Institutional Ownership - Frequently Asked Questions

Who are the largest shareholders of AQST shares?

During the previous two years, 16 institutional investors and hedge funds held shares of Aquestive Therapeutics. The most heavily invested institutionals were Armistice Capital LLC ($7.93M), Essex Investment Management Co. LLC ($1.71M), Vahanian & Associates Financial Planning Inc. ($1.20M), Acadian Asset Management LLC ($841K), Legato Capital Management LLC ($688K), Connor Clark & Lunn Investment Management Ltd. ($379K), and PFG Investments LLC ($204K).Learn more on AQST's institutional investors.

What percentage of Aquestive Therapeutics stock is owned by institutional investors?

32.45% of Aquestive Therapeutics stock is owned by institutional investors. Learn more on AQST's institutional investor holdings.

Which institutional investors have been buying Aquestive Therapeutics stock?

Of the 13 institutional investors that purchased Aquestive Therapeutics stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Armistice Capital LLC ($3.64M), Essex Investment Management Co. LLC ($846.17K), Acadian Asset Management LLC ($550.48K), Legato Capital Management LLC ($340.56K), Vahanian & Associates Financial Planning Inc. ($215.75K), Cowen AND Company LLC ($124.59K), and Mackenzie Financial Corp ($61.70K).

How much institutional buying is happening at Aquestive Therapeutics?

Institutional investors have bought a total of 5,985,926 shares in the last 24 months. This purchase volume represents approximately $9.59M in transactions.

Which Aquestive Therapeutics major shareholders have been selling company stock?

The following institutional investors have sold Aquestive Therapeutics stock in the last 24 months: Armistice Capital LLC ($876K), Vahanian & Associates Financial Planning Inc. ($557.32K), GSA Capital Partners LLP ($63.03K), HBK Sorce Advisory LLC ($42.35K), and Financial Advocates Investment Management ($7K).

How much institutional selling is happening at Aquestive Therapeutics?

Institutional investors have sold a total of 1,545,698 shares in the last 24 months. This volume of shares sold represents approximately $3.36M in transactions.


This page (NASDAQ:AQST) was last updated on 4/25/2024 by MarketBeat.com Staff

From Our Partners